This report was prepared by the European Commission’s Directorate-General for Research and Innovation.
Key results are that lump sums continue to be popular with users and are perceived as reducing the administrative burden. Lump sum funding puts more focus on the content of Horizon Europe grants and does not change the functioning of research and innovation projects. This confirms and extends the positive findings of the 2021 report. 

Read report of Lump Sum Funding

The report looks at the challenges faced by the industry and companies in the Single Market.

In a changing world with new challenges, the European Union is focused on staying competitive and prosperous. We're working hard to maintain our leadership globally and to make sure we have control over our own future. Therefore Europe needs to look further ahead and set out how to remain competitive. 

This is why Mario Draghi – former European Central Bank President and one of Europe's great economic minds – was tasked by the European Commission to prepare a report of his personal vision on the future of European competitiveness. 

Report of Draghi

The EU funded ERA4Health Partnership is preparing the future Joint Transnational Calls in the area of Cardiovascular Diseases; Nanomedicine; Nutrition and lifestyle- related disorders and in Prevention and Public Health.
Participate in the process by analysing the general Scope and Expected Impact of the 6 topics under discussion. Your opinion is important to define more appropriate and targeted goals for the next round of funded projects.
Read more on ERA4Health website

New Health Partnership for Rare Diseases.
To leave no one behind, over 170 organisations championed by the European Union and members states are working hand in hand to make Europe a world leader in rare diseases research and innovation. The European Rare Disease Research Alliance (ERDERA) takes over EJPRD to deliver concrete health benefits to rare disease patients in the next decade by advancing prevention, diagnosis and treatment research.

The European Union is expected to contribute around 150 million euros to this co-funded partnership via Horizon Europe, while the rest of the funding will come from members states, countries associated to Horizon Europe and in cash and in-kind contributions from public and private partners. 

ERDERA website

European Research Area – the new ERA 4 years on: achievements, lessons learnt and the way forward.
The Commission would like to hear your views.
This call for evidence is open for feedback. Your input will be taken into account as we further develop and fine-tune this initiative. Feedback received will be published on this site and therefore must adhere to the feedback rules.

Read more on the the EU website

Deadline for applications:

The applications must be sent by 30 September 2024, 23:59 (CET).

More information on Global Health EDCTP3 website

This report presents the interim evaluation of the Innovative Health Initiative (IHI) and the final evaluation of its predecessor, the Innovative Medicines Initiative (IMI2). The evaluation considers the programmes’ relevance, coherence, efficiency, effectiveness, EU-added value, as well as their additionality, directionality, international positioning and visibility, and transparency and openness, and presents lessons learned and suggestions for improvement.

Full study on the website of the Publications Office of the EU

This publication is the final report of the evaluation support study on Horizon Europe’s contribution to a Resilient Europe. It is an input into the interim evaluation of Horizon Europe, covering the period 2021-2023. The scope of the study covers three Clusters of Horizon Europe Pillar II:

1. Health
2. Culture, Creativity and Inclusive Society
3. Civil Security for Society

Additionally, it includes the Cancer Mission and seven partnerships.

Full study on the website of the Publications Office of the EU